Cappella Medical Devices Limited to Share Long Term Clinical Benefits of its Sideguard® Technology at EuroPCR 2012
5/15/2012 10:20:45 AM
PARIS--(BUSINESS WIRE)--Cappella Medical Devices Ltd (Cappella), a medical device company developing dynamic solutions for the treatment of coronary bifurcation disease, is pleased to announce new long term follow up clinical data for its innovative Sideguard® coronary sidebranch system. This new data, to be announced this week, continues to validate the importance of protecting the ostium with the unique scaffolding design of the Sideguard® stent resulting in long term preservation of the coronary sidebranch.
comments powered by